Gene · 5515
Papers3,188
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,188
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Heart saver: Comprehensive investigation of (redox-) proteomic and thiol metabolite changes induced by Cana-, Dapa-, Empagliflozin treatment in 2D and 3D heart cell models reveals increased mitochondrial activity and glutathione redox defense and involvement of redox signaling. | Life Sci | 2025 | 40840617 | PubTator, text mining | PubMed |
| Phosphoproteome-derived peptide libraries for deep specificity profiling of phosphatases and phospholyases. | bioRxiv | 2025 | 40832327 | PubTator, text mining | PubMed |
| Exploiting PP2A dependent and independent effects of forskolin for therapeutic targeting of KMT2A (MLL)-rearranged acute leukaemia. | Br J Pharmacol | 2025 | 40831365 | PubTator, text mining | PubMed |
| MicroRNA‑885‑5p regulates cell cycle progression in liver cancer cells. | Int J Mol Med | 2025 | 40808344 | PubTator, text mining | PubMed |
| Unlocking the therapeutic potential of the STING signaling pathway in anti-tumor treatment. | Clin Exp Med | 2025 | 40794212 | PubTator, text mining | PubMed |
| Triptolide targets PPP2CA/ITGA5 axis to suppress lactate-driven ovarian cancer progression. | Chin Med | 2025 | 40770810 | PubTator, text mining | PubMed |
| REGγ regulates antiviral response by activating TBK1-IFNβ signaling through degradation of PPP2CB. | Cell Mol Life Sci | 2025 | 40736577 | PubTator, text mining | PubMed |
| Houge-Janssens syndrome. | Eur J Hum Genet | 2025 | 40555839 | PubTator, text mining | PubMed |
| The 2023 European Union report on pesticide residues in food. | EFSA J | 2025 | 40371318 | PubTator, text mining | PubMed |
| Small extracellular vesicles: the origins, current status, future prospects, and applications. | Stem Cell Res Ther | 2025 | 40247402 | PubTator, text mining | PubMed |
| Midline-1 inhibited high glucose-induced epithelial-mesenchymal transition, fibrosis and inflammation through WNT/β-catenin signaling in benign prostatic hyperplasia. | Front Endocrinol (Lausanne) | 2025 | 40206598 | PubTator, text mining | PubMed |
| Study on mechanism of iridoid glycosides derivatives from Fructus Gardeniae in treatment of hepatic encephalopathy by network pharmacology and molecular docking technology. | Medicine (Baltimore) | 2025 | 40184133 | PubTator, text mining | PubMed |
| A chemical-genetic system to rapidly inhibit the PP2A-B56 phosphatase reveals a role at metaphase kinetochores. | Nat Commun | 2025 | 40157924 | PubTator, text mining | PubMed |
| Cerebral endothelial 3-mercaptopyruvate sulfurtransferase improves ischemia-induced cognitive impairment via interacting with protein phosphatase 2A. | Acta Pharm Sin B | 2025 | 40041885 | PubTator, text mining | PubMed |
| Pathogenic de novo variants in PPP2R5C cause a neurodevelopmental disorder within the Houge-Janssens syndrome spectrum. | Am J Hum Genet | 2025 | 39978342 | PubTator, text mining | PubMed |
| Transcriptomic profiles of single-cell autophagy-related genes (ATGs) in lung diseases. | Cell Biol Toxicol | 2025 | 39920481 | PubTator, text mining | PubMed |
| Wnt signaling inhibits casein kinase 1α activity by modulating its interaction with protein phosphatase 2A. | Cell Rep | 2025 | 39908140 | PubTator, text mining | PubMed |
| Downregulation of the phosphatase PHLPP1 contributes to NNK-induced malignant transformation of human bronchial epithelial cells (HBECs). | J Biol Chem | 2025 | 39863100 | PubTator, text mining | PubMed |
| Author Correction: R-loop-dependent promoter-proximal termination ensures genome stability. | Nature | 2025 | 39833484 | PubTator, text mining | PubMed |
| IMPDH2 dephosphorylation under FGFR signaling promotes S-phase progression and tumor growth. | Cell Rep | 2025 | 39739531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5515/papers?page=3